Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Euretos Provides Free Access to its AI Platform for Academic Researchers to Further Support Early Disease and Drug Research
Euretos is pleased to announce that access to its AI Platform will be available for […]
NHS Kicks Off ‘CPR Army’ Following Footballer’s Collapse
England’s top doctor is sending out an army of volunteers to teach CPR after international […]
HealthTech: Healing Health Care’s Ailments
By Frédérique Carrier, Head of Investment Strategy, RBC Wealth Management With bloated costs and gaps […]
More than 30 Million People Vaccinated with Second Dose
More than 30 million people in the UK have been vaccinated with a second dose […]
Breakthrough WHO Initiative Launched in Europe to Engage and Empower CSOs in Health Emergency Responses
Throughout the pandemic, civil society organizations (CSOs) have been crucial partners in reducing the impacts […]
BASMA.com Raises a $3M Series a Round to Scale Up Its Health Tech Platform in the MENA
BASMA.com is a digital healthcare platform working on redefining the orthodontics support experience with a […]
Synaptogenix Announces $12.5 Million Private Placement
Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced […]
£36 Million Boost for AI Technologies to Revolutionise NHS Care
New technology will help detect cancers and provide mental health support Projects are part of […]
Qure.ai ’s Brain CT AI Wins Funding from the NHS
The UK Department of Health and Social Care announced that Qure.ai has been selected as […]
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment
Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more